Faculty Opinions recommendation of Large transcription units unify copy number variants and common fragile sites arising under replication stress.

Author(s):  
Antony Carr
2014 ◽  
Vol 25 (2) ◽  
pp. 189-200 ◽  
Author(s):  
Thomas E. Wilson ◽  
Martin F. Arlt ◽  
So Hae Park ◽  
Sountharia Rajendran ◽  
Michelle Paulsen ◽  
...  

Oncogene ◽  
2007 ◽  
Vol 27 (23) ◽  
pp. 3256-3264 ◽  
Author(s):  
P K Tsantoulis ◽  
A Kotsinas ◽  
P P Sfikakis ◽  
K Evangelou ◽  
M Sideridou ◽  
...  

2013 ◽  
Vol 12 (1) ◽  
pp. 29 ◽  
Author(s):  
Xing Lu ◽  
Swetha Parvathaneni ◽  
Toshifumi Hara ◽  
Ashish Lal ◽  
Sudha Sharma

Cancers ◽  
2019 ◽  
Vol 11 (10) ◽  
pp. 1467 ◽  
Author(s):  
Xiaohua Wu

Rad52 in yeast is a key player in homologous recombination (HR), but mammalian RAD52 is dispensable for HR as shown by the lack of a strong HR phenotype in RAD52-deficient cells and in RAD52 knockout mice. RAD52 function in mammalian cells first emerged with the discovery of its important backup role to BRCA (breast cancer genes) in HR. Recent new evidence further demonstrates that RAD52 possesses multiple activities to cope with replication stress. For example, replication stress-induced DNA repair synthesis in mitosis (MiDAS) and oncogene overexpression-induced DNA replication are dependent on RAD52. RAD52 becomes essential in HR to repair DSBs containing secondary structures, which often arise at collapsed replication forks. RAD52 is also implicated in break-induced replication (BIR) and is found to inhibit excessive fork reversal at stalled replication forks. These various functions of RAD52 to deal with replication stress have been linked to the protection of genome stability at common fragile sites, which are often associated with the DNA breakpoints in cancer. Therefore, RAD52 has important recombination roles under special stress conditions in mammalian cells, and presents as a promising anti-cancer therapy target.


Open Biology ◽  
2018 ◽  
Vol 8 (4) ◽  
pp. 180018 ◽  
Author(s):  
Özgün Özer ◽  
Ian D. Hickson

Oncogene activation during tumour development leads to changes in the DNA replication programme that enhance DNA replication stress. Certain regions of the human genome, such as common fragile sites and telomeres, are particularly sensitive to DNA replication stress due to their inherently ‘difficult-to-replicate’ nature. Indeed, it appears that these regions sometimes fail to complete DNA replication within the period of interphase when cells are exposed to DNA replication stress. Under these conditions, cells use a salvage pathway, termed ‘mitotic DNA repair synthesis (MiDAS)’, to complete DNA synthesis in the early stages of mitosis. If MiDAS fails, the ensuing mitotic errors threaten genome integrity and cell viability. Recent studies have provided an insight into how MiDAS helps cells to counteract DNA replication stress. However, our understanding of the molecular mechanisms and regulation of MiDAS remain poorly defined. Here, we provide an overview of how DNA replication stress triggers MiDAS, with an emphasis on how common fragile sites and telomeres are maintained. Furthermore, we discuss how a better understanding of MiDAS might reveal novel strategies to target cancer cells that maintain viability in the face of chronic oncogene-induced DNA replication stress.


2018 ◽  
Author(s):  
Lora Boteva ◽  
Ryu-Suke Nozawa ◽  
Catherine Naughton ◽  
Kumiko Samejima ◽  
William C Earnshaw ◽  
...  

Cells coordinate interphase to mitosis transition but recurrent cytogenetic lesions appear at common fragile sites (CFSs) in a tissue-specific manner following replication stress, marking regions of instability in cancer. Despite such a distinct defect no model fully explains their molecular configuration. We show that CFSs are characterised by impaired chromatin folding manifested as disrupted mitotic structures visible using molecular FISH probes in the presence and absence of replication stress. Chromosome condensation assays reveal that compaction-resistant chromatin lesions persist at CFSs throughout the cell cycle and mitosis. Subsequently cytogenetic and molecular lesions arise due to faulty condensin loading at CFSs, through a defect in condensin I mediated compaction and are coincident with mitotic DNA synthesis (MIDAS). This model suggests that in conditions of exogenous replication stress, aberrant condensin loading leads to molecular defects and CFS formation, concomitantly providing an environment for MIDAS, which, if not resolved, result in chromosome instability.


Cell Reports ◽  
2020 ◽  
Vol 32 (12) ◽  
pp. 108177 ◽  
Author(s):  
Lora Boteva ◽  
Ryu-Suke Nozawa ◽  
Catherine Naughton ◽  
Kumiko Samejima ◽  
William C. Earnshaw ◽  
...  

Cell Research ◽  
2020 ◽  
Vol 30 (11) ◽  
pp. 997-1008 ◽  
Author(s):  
Morgane Macheret ◽  
Rahul Bhowmick ◽  
Katarzyna Sobkowiak ◽  
Laura Padayachy ◽  
Jonathan Mailler ◽  
...  

Abstract DNA replication stress, a feature of human cancers, often leads to instability at specific genomic loci, such as the common fragile sites (CFSs). Cells experiencing DNA replication stress may also exhibit mitotic DNA synthesis (MiDAS). To understand the physiological function of MiDAS and its relationship to CFSs, we mapped, at high resolution, the genomic sites of MiDAS in cells treated with the DNA polymerase inhibitor aphidicolin. Sites of MiDAS were evident as well-defined peaks that were largely conserved between cell lines and encompassed all known CFSs. The MiDAS peaks mapped within large, transcribed, origin-poor genomic regions. In cells that had been treated with aphidicolin, these regions remained unreplicated even in late S phase; MiDAS then served to complete their replication after the cells entered mitosis. Interestingly, leading and lagging strand synthesis were uncoupled in MiDAS, consistent with MiDAS being a form of break-induced replication, a repair mechanism for collapsed DNA replication forks. Our results provide a better understanding of the mechanisms leading to genomic instability at CFSs and in cancer cells.


2021 ◽  
Vol 12 ◽  
Author(s):  
Wei Wu ◽  
Jing Na He ◽  
Mengjiao Lan ◽  
Pumin Zhang ◽  
Wai Kit Chu

Accurate replication of the entire genome is critical for cell division and propagation. Certain regions in the genome, such as fragile sites (common fragile sites, rare fragile sites, early replicating fragile sites), rDNA and telomeres, are intrinsically difficult to replicate, especially in the presence of replication stress caused by, for example, oncogene activation during tumor development. Therefore, these regions are particularly prone to deletions and chromosome rearrangements during tumorigenesis, rendering chromosome fragility. Although, the mechanism underlying their “difficult-to-replicate” nature and genomic instability is still not fully understood, accumulating evidence suggests transcription might be a major source of endogenous replication stress (RS) leading to chromosome fragility. Here, we provide an updated overview of how transcription affects chromosome fragility. Furthermore, we will use the well characterized common fragile sites (CFSs) as a model to discuss pathways involved in offsetting transcription-induced RS at these loci with a focus on the recently discovered atypical DNA synthesis repair pathway Mitotic DNA Synthesis (MiDAS).


Sign in / Sign up

Export Citation Format

Share Document